Clinical Efficacy of Ustekinumab in Crohn's Disease

A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China

NCT06082986 ·Status: COMPLETED

A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)

NCT07310095 ·Status: RECRUITING ·Phase: PHASE4

Intestinal Epithelial Fucosylation Affects the Efficacy of Ustekinumab in Crohn's Disease

NCT06203158 ·Status: COMPLETED

Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study

NCT06802887 ·Status: RECRUITING

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

NCT03466411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

NCT02968108 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

NCT01369329 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ustekinumab Treatment in Children With Crohn's Disease

NCT05242458 ·Status: COMPLETED

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

NCT04372108 ·Status: RECRUITING

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab

NCT03107793 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

NCT01369342 ·Status: COMPLETED ·Phase: PHASE3

Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease

NCT06739278 ·Status: NOT_YET_RECRUITING

A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

NCT00265122 ·Status: COMPLETED ·Phase: PHASE2

Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization.

NCT06912815 ·Status: RECRUITING ·Phase: NA

Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease

NCT03495973 ·Status: COMPLETED

A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

NCT01369355 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

NCT05029921 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

NCT03464136 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

NCT03358706 ·Status: TERMINATED ·Phase: PHASE1

Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study

NCT07149467 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

NCT00771667 ·Status: COMPLETED ·Phase: PHASE2

An Analysis of the Relationship Between the Genetic Polymorphisms of Interleukin 12 Receptor Subunit Beta 1 and Crohn's Disease in Chinese Patients

NCT07057856 ·Status: COMPLETED

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

NCT05347095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease

NCT06520397 ·Status: RECRUITING ·Phase: PHASE4

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

NCT07242248 ·Status: RECRUITING